Fideuram Asset Management Ireland dac Makes New Investment in Cardinal Health, Inc. $CAH

Fideuram Asset Management Ireland dac bought a new position in shares of Cardinal Health, Inc. (NYSE:CAH) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 8,716 shares of the company’s stock, valued at approximately $1,768,000.

A number of other hedge funds also recently added to or reduced their stakes in CAH. Aventura Private Wealth LLC acquired a new stake in Cardinal Health during the 4th quarter worth approximately $25,000. Jones Financial Companies Lllp lifted its holdings in Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. JPL Wealth Management LLC acquired a new stake in Cardinal Health during the 3rd quarter worth approximately $31,000. Turning Point Benefit Group Inc. purchased a new stake in shares of Cardinal Health in the 3rd quarter valued at approximately $31,000. Finally, Cape Investment Advisory Inc. increased its position in shares of Cardinal Health by 61.1% in the 3rd quarter. Cape Investment Advisory Inc. now owns 211 shares of the company’s stock valued at $33,000 after purchasing an additional 80 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE CAH opened at $196.57 on Friday. The firm’s fifty day moving average price is $203.52 and its 200 day moving average price is $208.79. The company has a market capitalization of $46.04 billion, a price-to-earnings ratio of 30.06, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, beating analysts’ consensus estimates of $2.79 by $0.38. The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The company’s revenue was up 11.0% on a year-over-year basis. During the same period last year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a $0.5158 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s payout ratio is 31.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. Zacks Research raised shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Barclays increased their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, February 24th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Leerink Partners reissued an “outperform” rating and issued a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Finally, Weiss Ratings downgraded shares of Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Tuesday, May 19th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.